ARCHIVES

Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission

This article is from The Cancer Letter archive.

Vol. 07 No. 04 | January 23, 1981

Download PDF Visit The Full Archive

Related Articles

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

DCPC Board OKS P01 Grants Program In Nutrition Research

March 11, 1994

NCAB Meeting Moved To October

July 20, 1979

CIS Cost Sharing Feasibility Study Recommended

December 11, 1987

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Protest Erupts Over Charge That NCAB Directives On CCOP Are Ignored; “Misunderstanding,” DeVita Says

June 25, 1982